Similar Articles
651 Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer
652 Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
653 Risk scores, prevention, and treatment of maternal venous thromboembolism
654 Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma
655 Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment
656 Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma
657 Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations
658 Pathological characterization of occult hepatitis B virus infection in hepatitis C virus-associated or non-alcoholic steatohepatitis-related hepatocellular carcinoma
659 Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors
660 Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA